Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its latest quarterly report later this week. Analysts are predicting strong performance driven by the robust https://umairyzva682696.designi1.com/57786998/eli-lilly-stock-a-deep-dive-into-q3-earnings